Forma Therapeutics Holdings, Inc. Common Stock
FMTX
FMTX was delisted on the 13th of October, 2022.
82 hedge funds and large institutions have $1.01B invested in Forma Therapeutics Holdings, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 36 increasing their positions, 18 reducing their positions, and 18 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 18
6% less funds holding
Funds holding: 87 → 82 (-5)
6.98% less ownership
Funds ownership: 92.21% → 85.23% (-7%)
12% less capital invested
Capital invested by funds: $1.14B → $1.01B (-$131M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
28% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$23.1M |
| 2 |
State Street
Boston,
Massachusetts
|
+$8.14M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$4.59M |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$4.56M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$2.84M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$35M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
-$5.24M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.21M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.67M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.44M |
FMTX Hedge Fund Activity: Q2 2021 in Review
82 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Forma Therapeutics Holdings, Inc. Common Stock (FMTX) for Q2 2021, worth a combined $1.01B — down 12% from $1.14B a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of FMTX and 13 opened new positions — a net loss of 5 holders — while 18 trimmed existing stakes and 36 added.
The largest buyer was Fidelity Investments, adding an estimated $23.1M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $35M sold.
- 82 institutional investors held Forma Therapeutics Holdings, Inc. Common Stock (FMTX) as of Q2 2021, down from 87 in Q1 2021.
- Funds reported $1.01B of Forma Therapeutics Holdings, Inc. Common Stock stock for Q2 2021, down 12% quarter-over-quarter.
- 13 funds opened new Forma Therapeutics Holdings, Inc. Common Stock positions in Q2 2021 and 18 closed out, a net change of -5 holders.
- The largest Forma Therapeutics Holdings, Inc. Common Stock buyer in Q2 2021 was Fidelity Investments, an estimated $23.1M added.
- The largest Forma Therapeutics Holdings, Inc. Common Stock seller in Q2 2021 was Perceptive Advisors, an estimated $35M sold.
Based on aggregated 13F filings for Q2 2021.